Sá, Juliana and Costelha, João and Marinho, Antonio (2019) Inclusion Body Myositis Treated with Alemtuzumab. European Journal of Case Reports in Internal Medicine, 6 (12). ISSN 2284-2594
|
Text
document (1).pdf - Published Version Download (171kB) | Preview |
Abstract
Inclusion body myositis (IBM) is a chronic inflammatory myopathy with a progressive course. It is more common in the later years of life and usually presents with limb weakness. We present the case of a patient who developed proximal weakness in the lower limbs and, four years later, facial asymmetry. Blood analysis revealed high lactate dehydrogenase and creatinine kinase values. The diagnosis was obtained through muscle biopsy which met the histological criteria for IBM. The patient started treatment with alemtuzumab, leading to stabilisation of the symptoms in two years.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Inclusion body myositis, alemtuzumab, myopathy, treatment |
| Subjects: | 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale) |
| Depositing User: | Chiara D'Arpa |
| Date Deposited: | 19 Nov 2020 09:43 |
| Last Modified: | 19 Nov 2020 09:43 |
| URI: | http://eprints.bice.rm.cnr.it/id/eprint/19664 |
Actions (login required)
 |
View Item |
